FIELD: medicine.
SUBSTANCE: to stimulate muscle mass and/or muscle function, a combination of 5 mg to 200 mg of nandrolone or its ester and from 17.5 μg to 15 mg of cholecalciferol and sesame oil is administered concomitantly at the age of 60 years or older. A pharmaceutical composition and application of a composition for muscle mass and/or muscle function stimulation in elderly patients are also provided.
EFFECT: group of inventions provides stimulating effect on muscle mass and stimulates muscle function in elderly patients.
10 cl, 3 dwg, 1 tbl, 3 ex
Title |
Year |
Author |
Number |
PHARMACEUTICAL FORMULATIONS AND METHODS INCLUDING COMBINATIONS OF 2-ALKYLIDEN DERIVATIVES OF 9-NOR-VITAMIN D AND BISPHOSPHONATE |
2004 |
|
RU2326695C2 |
DERIVATIVES OF 2-ALKYLIDEN-19-NOR-VITAMIN D FOR TREATMENT OF WEAKNESS, MUSCULAR INVOLVEMENT OR SARCOPENY |
2004 |
|
RU2326674C2 |
HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT AND PREVENTION OF CANCER |
2019 |
- Garcia, Victor, P
- Espino De Paz, Carmen D
- Perez Espino, Carla
- Perez Espino, Alfredo
|
RU2794340C1 |
SUSTAINED RELEASE SYSTEMS AND LOW DOSES OF ANDROGENS, METHODS OF THEIR PREPARING AND METHOD OF TREATMENT USING THESE SYSTEMS |
1992 |
- Fernan Labri
- Marten Lepazh
|
RU2142276C1 |
FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS |
2003 |
- Mejssner Robert S.
- Perkins Dzhejms Dzh.
|
RU2320670C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN |
2007 |
- Arinbasarov Mikhail Utevlevich
- Kogan Vladimir Il'Ich
- Mezhburd Evgenij Vol'Fovich
|
RU2379043C2 |
USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM |
2013 |
- Deluka Gektor F.
- Plam Lori A.
- Zella Dzhuliya B.
- Klagett-Dejm Margaret
|
RU2666995C2 |
COMPOUNDS, METHOD FOR THEIR PREPARING, METHODS OF TREATMENT |
2002 |
|
RU2296121C2 |
AGENT FOR PREVENTING AND TREATING NEURODEGENERATIVE PATHOLOGY AND VASCULAR DEMENTIA (VERSIONS) |
2014 |
- Gromova Olga Alekseevna
- Torshin Ivan Jurevich
|
RU2582962C1 |
COMPOSITIONS AND PRODUCTS FOR USE IN TREATING FRACTURES AND BONE DEFECTS |
2015 |
|
RU2697873C2 |